Article
Role of P53-Senescence Induction in Suppression of LNCaP Prostate Cancer Growth by Cardiotonic Compound Bufalin.
Molecular cancer therapeutics - 1 Nov 2018
Zhang Yong, Dong Yinhui, Melkus Michael W, Yin Shutao, Tang Su-Ni, Jiang Peixin, Pramanik Kartick, Wu Wei, Kim Sangyub, Ye Min, Hu Hongbo, Lu Junxuan, Jiang Cheng
Abstract excerpt
Bufalin is a major cardiotonic compound in the traditional Chinese medicine, Chansu, prepared from toad skin secretions. Cell culture studies have suggested an anticancer potential involving multiple cellular processes, including differentiation, apoptosis, senescence, and angiogenesis. In prostate cancer cell models, P53-dependent and independent caspase-mediated apoptosis and androgen receptor (AR) antagonism...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
